Effect of Exercise Training and +Gz Acceleration Training on Men by Stocks, Jodie M. et al.
Source of Acquisition 
NASA Ames Research Center 
NASA/TM-2001-210926 
Effect of Exercise Training and +Gz Acceleration 
Training on Men 
John E. Greenlea$ Shawn R. Simonson, Jodie M. Stocks, Joyce Evans, Charles F: Knapp, 
Stephenie A. Cowell, Kendra N. Pemberton, Heather W Wilson, Jamie M. Venel; Simon N. 
Evetts, Peter A. Hardy, Richard E. Grindeland, Helmut Hinghofer-Szalhy, Scott M. Smith, 
Michael G. Zieglel; David R. Brown, David G. Evans, Fritz B. Moore, and David i? Quach 
~~~~ 
September 2001 
https://ntrs.nasa.gov/search.jsp?R=20060050756 2019-08-29T23:55:09+00:00Z
The NASA STI Program Office . . . in Profile 
Since its founding, NASA has been dedicated to the 
advancement of aeronautics and space science. The 
NASA Scientific and Technical Information (STI) 
Program Office plays a key part in helping NASA 
maintain this important role. 
The NASA STI Program Office is operated by 
Langley Research Center, the Lead Center for 
NASA's scientific and technical information. The 
NASA STI Program Office provides access to the 
NASA STI Database, the largest collection of 
aeronautical and space science STI in the world. 
The Program Office is also NASA's institutional 
mechanism for disseminating the results of its 
research and development activities. These results 
are published by NASA in the NASA STI Report 
Series, which includes the following report types: 
* TECHNICAL PUBLICATION. Reports of 
completed research or a major significant phase 
of research that present the results of NASA 
programs and include extensive data or theoreti- 
cal analysis. Includes compilations of significant 
scientific and technical data and information 
deemed to be of continuing reference value. 
NASA's counterpart of peer-reviewed formal 
professional papers but has less stringent 
limitations on manuscript length and extent 
of graphic presentations. 
TECHNICAL MEMORANDUM. Scientific and 
technical findings that are preliminary or of 
specialized interest, e.g., quick release reports, 
working papers, and bibliographies that contain 
minimal annotation. Does not contain extensive 
analysis. 
* CONTRACTOR REPORT. Scientific and 
technical findings by NASA-sponsored 
contractors and grantees. 
* CONFERENCE PUBLICATION. Collected 
papers from scientific and technical confer- 
ences, symposia, seminars, or other meetings 
sponsored or cosponsored by NASA. 
SPECIAL PUBLICATION. Scientific, technical, 
or historical information from NASA programs, 
projects, and missions, often concerned with 
subjects having substantial public interest. 
TECHNICAL TRANSLATION. English- 
language translations of foreign scientific and 
technical material pertinent to NASA's mission. 
Specialized services that complement the STI 
Program Office's diverse offerings include creating 
custom thesauri, building customized databases, 
organizing and publishing research results . . . even 
providing videos. 
For more information about the NASA STI 
Program Office, see the following: 
Access the NASA STI Program Home Page at 
http://www. sti. nma. gov 
E-mail your question via the Internet to 
help@ sti.nasa.gov 
Fax your question to the NASA Access Help 
Desk at (301) 621-0134 
Telephone the NASA Access Help Desk at 
(301) 621-0390 
Write to: 
NASA Access Help Desk 
NASA Center for Aerospace Information 
7121 Standard Drive 
Hanover, MD 2 1076- 1 320 
NASA/TM-2001-210926 
Effect of Exercise Training and +Gz Acceleration 
Training on Men 
John E. Greenleafi, Shawn R. Simonson2, Jodie M. Stocks', Joyce M. Evans3, Charles I? Knapp3, 
Stephenie A. Cowel12, Kendra N. Pemberton', Heather W Wilson', Jamie M. Vene9, Simon N. 
Evetts6, Peter A. Hardf, Richard E. Grindeland', Helmut Hinghofer-Szalkay7, Scott M. Smith8, 
Michael G. Zieglefl, David R. Brown3, David G. Evand, Fritz B. Moorelo, and David T Quach' 
'NASA Ames Research Centel; Moffett Field, CA 94035-1 000; 2Lockheed Martin Space Opera- 
tions Corporation, NASA Ames Research Centel; Moflett Field, CA 94035-1000; 3University of 
Kentucky, Lexington, KY 40506; 'Sun Francisco State University, Sun Francisco, CA 941 32; 
5California State University, Fresno, CA 93740-801 8; 6King's College London, London W8 7AH, 
England; 71nstitute for Adaptive and Spaceflight Physiology, A-801 0 Graz, Austria; 8NASA, 
Johnson Space Center, Houston, TX 77058-3696; 9University of California, Sun Diego, CA 
921 03-8341; 'OUniversity of California, Davis, CA 9.5616-8741 
National Aeronautics and 
Space Administration 
Ames Research Center 
Moffett Field, California 94035- 1000 
September 2001 
Acknowledgments 
The authors thank: for management and technical assistance - B.M. Asagi, P.R. Barnes, A. 
Bognar, T. Burchell, M. Crellin, J.B. Griffith, D.P. Gundo, J.F. Kaumeyer, J.A. 
Ludgate, S.G. Lumidao, C.M. McIntosh, R.T. Merlo, A.R. Patwardhan, T. Purce 
M. Stenger, and R.O. Talavera; for blood drawing - K. Campbell, J.D. Pavloff, and G. Shinn; for 
medical monitoring - B. Kharrazi, R. Pelligra, and S. Sastry; for manuscript preparation and 
editing - C.A. Barton, J.M. Donald, and L.N. Popish; and the test subjects for their splendid 
cooperation. 
Extant Presentations and Publications 
Evans, J.M., S.R. Simonson, C.K. Knapp, J.M. Stocks, H.W. Biagini, S.A. Cowell, K.N. Bailey, 
J.M. Vener, S.N. Evetts, F.B. Moore, M.B. Stenger, C.M. McIntosh, and J.E. Greenleaf. 
Differences in acceleration training and exercise training on resting cardiovascular vari- 
ables. FASEB J. 14: A616,2000. Abstract. 
Evans, J.M., M.B. Stenger, E. Kwong, C.M. McIntosh, D.R. Brown, A.R. Patwardhan, C.F. 
Knapp, SR Simonson, JM Stocks, SA Cowell, KN Bailey, JM Vener, SN Evetts, F'B 
Moore, and MG Ziegler.. Human powered centrifuge training on cardiovascular re- 
sponses to head up tilt. FASEB J. 15: A795,2001. Abstract. 
Knapp, C.F., M.B. Stenger, E. Kwong, C.M. McIntosh, D.R. Brown, A.R. Patwardhan, J.M. 
Evans, S.R. Simonson, J.M. Stocks, H.W. Biagini, S.A. Cowell, K.N. Bailey, J.M. Vener, 
S.N. Evetts, F.B. Moore, and M.G. Ziegler. Passive acceleration training and cardiovascu- 
lar responses to head up tilt. FASEB J. 15: A795, 2001. Abstract. 
Pemberton, K.N.B. The Effects of Passive +Gz and Exercise Plus +Gz Training on Orthostatic 
Tolerance. M.A. Thesis; Department of Biology: Physiology and Behavioral Biology, 
San Francisco State University, September 2000.84~. 
Simonson, S.R., S.A. Cowell, J.M. Stocks, H.W. Biagini, J.M. Vener, S.N. Evetts, K.N. Bailey, 
J.M. Evans, C.F. Knapp, and J.E. Greenleaf. The impact of passive acceleration and 
exercise plus acceleration on work capacity and orthostasis. 13& I.A.A. Humans in Space 
Symposium: Exploring Space. Santorini, Greece, May 20-26,2000. 
Vener, T.M. Cardiod.monarv Responses to Incremental Supine Cycle Er2omeh-y with Con- 
comitant +Gz Acceleration. M.A. Thesis; Department of Kinesiology, California State 
University, Fresno, May 2000.92~. 
Available from: 
NASA Center for Aerospace Information 
7121 Standard Drive 
Hanover, MD 21076-1320 
(301) 621-0390 
National Technical Information Service 
5285 Port Royal Road 
Springfield, VA 22161 
(703) 487-4650 
CONTENTS 
ACKNOWLEDGMENTS .............................................................................................................. iv 
SUMMARY ..................................................................................................................................... 1 
INTRODUCTION ........................................................................................................................... 3 
METHODS ...................................................................................................................................... 4 
Approval ..................................................................................................................................... 4 
Subjects ...................................................................................................................................... 4 
Human-Powered Centrifuge ....................................................................................................... 4 
Design. construction. operation. and instnunentation 
__ 
Protocol ...................................................................................................................................... 6 
Tests And Measurements .......................................................................................................... 11 
Maximal ...... uptake (VO. max) ................................................................................ 
Maximal human-powered centrifuge protocol ..................................................................... 14 
Tilt-table (orthostasis) protocol ........................................................................................... 15 
Blood sampling and analyses .............................................................................................. 18 
Urine collection and analyses .............................................................................................. 21 
Magnetic resonance imaging (MRI) ................................................................................... 21 
DATA ANALYSES ........................................................................................................................ 22 
Hemodynamic ................................................................................................ .Z ......................... 22 
statistical ................................................................................................................................... 22 
RESULTS ...................................................................................................................................... 23 
Maximal Exercise (Passive, Exercise, Combined) Data ............................................................. 23 
Exercise load ....................................................................................................................... 23 
V 
Oxygen uptake .................................................................................................................... 23 
Heart rate ............................................................................................................................ 23 
Exercise tolerance ............................................................................................................... 23 
Orthostatic (Tilt-Table) Cardiovascular Data ............................................................................. 23 
Resting pre-tilt heart rate ..................................................................................................... 23 
Resting pre-tilt systolic blood pressure ............................................................................... 23 
Resting pre-tilt diastolic blood pressure .............................................................................. 23 
Resting pre-tilt mean arterial pressure ................................................................................. 23 
Tilt-tolerance time ............................................................................................................... 24 
Heart rate at tolerance .......................................................................................................... 24 
Mean arterial pressure at tolerance ...................................................................................... 24 
Cardiac R-R interval with training ....................................................................................... 24 
Stroke volume with training ................................................................................................ 24 
End diastolic volume with training ...................................................................................... 24 
Cardiac output with training ................................................................................................ 24 
. .  Cuff arterial pressure with t r~Iung ...................................................................................... 24 
Total peripheral resistance with training .............................................................................. 24 
Cardiovascular variables ...................................................................................................... 24 
Orthostatic (Tilt-Table) Biochemical Data ................................................................................. 24 
Blood hemoglobin .............................................................................................................. 24 
Raw hematocrit ................................................................................................................... 25 
Plasma volume ................................................................................................................... -25 
Plasma sodium .................................................................................................................... 25 
vi 
Plasma potassium ............................................................................................................... 25 
Plasma osmolality ..... '. ......................................................................................................... 25 
Plasma albumin ................................................................................................................... 25 
Plasma total protein ............................................................................................................. 25 
Plasma renin activity ........................................................................................................... 26 
Plasma aldosterone ............................................................................................................. 26 
Plasma vasopressin ............................................................................................................. 26 
Plasma epinephrine ............................................................................................................. 26 
Plasma norepinephrine ........................................................................................................ 26 
Plasma dopamine ................................................................................................................ 26 
Plasma growth hormone ..................................................................................................... 26 
Urine Data (24 hour) ................................................................................................................ 27 
Volume and rate (24 hr) ...................................................................................................... 27 
. .  C r e a ~ ~ n e  ............................................................................................................................ 27 
Deoxyp yridinoline .............................................................................................................. 27 
Deoxypyridinoline / creatinine ratio .................................................................................... 27 
n-Telopeptide ...................................................................................................................... 27 
n-Telopeptide / Creatinine ratio ............................................................................................ 27 
Pyridinium crosslinks ......................................................................................................... 27 
Pyridinium crosslinks / creatinine ratio ............................................................................... 27 
Hydroxyproline .................................................................................................................. 27 
Hydroxyproline / creatinine ratio ........................................................................................ 27 
Calcium ............................................................................................................................. 2 7  
Magnetic Resonance Imaging ................................................................................................... 27 
Volume .............................................................................................................................. -27 
Excitation ............................................................................................................................ 27 
SUMMARY OF RESULTS ........................................................................................................... 28 
RlEFERENCES ............................................................................................................................... 30 
APPENDICES ............................................................................................................................... 36 
A: A1 - A4 . Protocol Approvals ............................................................................................... 36 
B: B1 - B2 . G-level vs . RPM ................................................................................................... 40 
C: Instruments and Equipment Inventory .................................................................................. 42 
D: Borg Intensity of Perceived Exertion Scale .......................................................................... 46 
E: CPX Oxygen Analyzer Calibration ....................................................................................... 47 
F: Raw Data .............................................................................................................................. 48 
G: Figures (12 to 57) ................................................................................................................ 93 
EFFECT OF EXERCISE TRAINING AND +Gz ACCELERATION 
TRAINING ONlMEN 
John E. Greenleaf’, Shawn R. Simonson2, Jodie M. Stocks’, Joyce M. Evans3, Charles F. Knapp3, 
Stephenie A. Cowel12, Kendra N. Pemberton4, Heather W. Wilson’, Jamie M. Vene8, Simon N. 
Evetts6, Peter A. Hardy3, Richard E. Grindeland’, Helmut Hinghofer-Szalkay7, Scott M. Smith’, 
Michael G. Ziegler’, David R. Brown3, David G. Evans4, Fritz B. Moore”, and David T. Quach’ 
SUMMARY 
Reduction in work capacity (maximal oxygen uptake) during flight and enhanced orthostatic 
intolerance during reentry, landing, and egress from the return vehicle are continuing problems that 
have not been solved. Intennittent, high-intensity, short-duration isotonic cycle ergometer exercise 
training can maintain work capacity at ambulatory control levels over 1 month of bed-rest (BR)- 
deconditioning, and short-arm (< 2-meter radius) +Gz (head-to-foot) acceleration training without and 
with concomitant exercise can attenuate the usual orthostatic intolerance resulting from water- 
immersion or bed-rest deconditioning. Thus, the purpose for this study was to test the hypothesis that 
(1) passive-acceleration training; supine-interval-exercise plus acceleration training; and exercise 
combined with acceleration training would improve orthostatic tolerance in ambulatory men; and that 
(2) addition of the aerobic exercise conditioning would not alter this improved tolerance from that of 
passive-acceleration training. 
Seven men (24-38 years) were test subjects. Three men underwent “Passive” training on the 
Ames human-powered centrifuge (HPC) for 30 min (warm-up, then 24 min of 2-min acceleration 
intervals (+1.0 Gz to 50% Gz- at +2.4 & 0.1 Gz), and cool-down) for 5 days/week for 3 weeks. 
Three other subjects underwent constant +Gz acceleration (50% of HPC maximal acceleration at +2.3 
k 0.2 Gz) while performing “Exercise” training on the cycle ergometer at 40% of maximal oxygen 
Laboratory for Human Environmental Physiology, NASA, Ames Research Center, Moffett Field, 
Calif. 94035- 1OOO; 2Lockheed Martin Space Operations Corporation, NASA, Ames Research Center, 
Moffett Field, Calif. 94035-1000; 3Center for Biomedical Engineering, University of Kentucky, 
Lexington, Ky. 40506; 4Department of Biology: Physiology and Behavioral Biology, San Francisco 
State University, San Francisco, Calif. 94132; ’Department of Kinesiology, California State University, 
Fresno, Calif. 93740-8018; 6Biomedical Sciences Division, King’s College London, London W8 7AH, 
England; 71nstitute for Adaptive and Spaceflight Physiology, A-8010 Graz, Austria; ‘Life Sciences 
Research Laboratories, NASA, Johnson Space Center, Houston, Tex. 77058-3696; 9GCRC, UCSD 
Medical Center, University of California, San Diego, Calif. 92103-8341; ‘!Department of Neurology, 
Physiology, and Behavior, University of California, Davis, Calif. 95616-8741. 
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uptake (VQrnax), then 24 min of 2-min intervals (40% - 90% Vi2max) for 5 days/week for 3 weeks. A 
crossover design utilized 4 weeks of ambulatory deconditioning between sessions. Six subjects also 
underwent similar “Combined” exercise training at 40% to 90% of the HPC +Gz- exercise level. 
Before and after each training session the maximal PO2, workload, and heart rate (HR) were determined 
supine using a ramped cycle ergometer protocol. Resting HR and blood pressures (systolic, diastolic, 
and mean arterial) were measured, pre- and post-training, after 40 min of supine rest and for 1 min 
before determination of orthostatic tolerance to 70” head-up tilt. 
Maximal human-powered (Passive, Exercise. Combined) data. Maximal supine exercise loads 
increased significantly (P < 0.05) by 8.3% (Passive Phase), 12.6% (Exercise Phase), and 15.4% 
(Combined Phase) after training, but the subjects’ post-training maximal oxygen uptakes and maximal 
heart rates were unchanged from their respective pre-training levels. Maximal time to fatigue 
(endurance) was unchanged with Passive, but was also increased (P < 0.05) with Exercise and 
Combined training. Thus, the exercise in the Exercise and Combined training Phases resulted in greater 
maximal loads and endurance without effect on maximal oxygen uptake or heart rate. 
Orthostatic (tilt-table) cardiovascular data. Resting pre-tilt heart rate was elevated by 12.9% 
(P < 0.05) only after Passive training, suggesting that the exercise training attenuated the H R  response. 
Resting pre-tilt blood pressures (SBR, DBP, MAP) were not different pre- or post-training in any 
Phase. Post-training tilt-tolerance time and heart rate were increased (P < 0.05) only with Passive 
training, by 37.8% and by 29.1%, respectively. Thus, addition of exercise training appeared to attenuate 
the increased Passive tolerance. Resting @re-tilt) and post-tilt cardiac R-R interval, stroke volume, end- 
diastolic volume, and cardiac output were all uniformly reduced (P < 0.05), and peripheral resistance 
was uniforrdy increased (P < 0.05) pre- and post-training for the three Phases, indicating no effect of 
the exercise training on these cardiovascular variables. 
Orthostatic (tilt-table) biochemical data. Plasma volume (percent change) was unifonnly decreased 
by 8% to 14% (P < 0.05) at tilt-tolerance pre-training versus post-training, indicating essentially no 
effect of training on the level of hypovolemia. The latter was reflected in the 6% to 12% (P < 0.05) 
increase in plasma aldosterone FA] and plasma total protein [PTP] concentrations. Percent changes in 
plasma sodium concentration IpNa] pre-training versus post-training were minimal (less than -0.8%) 
as was plasma osmolality [POsm] (less than -0.4%) indicating essentially isotonic plasma shifts during 
tilting. Pre- and post-training percent changes in plasma renin activity (PRA), plasma aldosterone 
concentration [PA], plasma epinephrine concentration PE], and IpNa] exhibited similar characteristic 
increases at tolerance; the usual increase in plasma vasopressin concentration [PVP] was greatly 
attenuated post-training with Exercise and also pre- and post-training with Combined. The explanation 
for the latter is not obvious but is unlikely a result of technical errors. 
Urine data (24-hr). Urinary volumes were within normal limits (1.2 to 1.5 ml*min-’) between and 
among pre- and post-training samples for the three Phases. There were no significant differences 
between or among the 10 urinary variables pre-training and post-training for the three Phases. 
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INTRODUCTION 
Long-duration (> 1 -yr) human spaceflight will require refinement of current physiological 
countermeasures, as well as implementation of others to allay deconditioning of crew members - 
defined as attenuation of their physical fitness. Crew exposure to weightlessness in the spaceflight 
environment of moderate confinement, restricted mobility, and enhanced ionizing radiation affects every 
organ system in the body that contributes to deconditioning (Convertino, 1990; Nicogossian, 1994; 
Sonnenfeld, 1998; Zerath, 1998). Effects of deconditioning such as reduction of maximal work 
capacity (Greenleaf et al., 1989), bone density and strength (LeBlanc et al., 1990,1996), muscle mass 
and strength Ellis et al., 1993; Greenleaf et al., 1994), orthostatic tolerance (Buckey et al., 1996), and 
neurovestibular sensitivity (Collins et al., 1995; Paloski et al., 1992) can lead to decreased crew health, 
safety, and productivity during flight, especially during and immediately after landing on a planet with a 
physiologically significant gravitational force (Buckey et al., 1996; Burton, 1988; Kotovskaya et al., 
1977; Nicogossian, 1994). 
Short arm (e 2-m radius) +Gz (head-to-foot) acceleration training without (Shulzhenko et al., 1976, 
1979; Vil-Viliams, 1994) and with (Vil-Vilyams and Shulzhenko, 1980) concomitant exercise training 
has been reported to significantly attenuate the usual orthostatic intolerance resulting from water- 
immersion deconditioning. In addition, the data of White et al. (1966) indicated that the consistent 
intolerance to 20 min of 70" head-up tilt after prolonged BR-deconditioning was reduced or alleviated 
by daily intermittent +1.75 Gz (4.7 G-hr) training periods without exercise during 10 days of 
horizontal BR as reviewed by Stone et al. (1966). Also, intensive, intermittent cycle ergometer exercise 
training can maintain aerobic exercise capacity (maximal oxygen uptake) at ambulatory control levels 
during 30 days of 6" head-down BR (Greenleaf et al., 1989; Kakurin et al., 1978). Performing exercise 
with acceleration has been proposed as a timeLefficient countermeasure to attenuate the reduction in 
both exercise capacity and orthostatic tolerance simultaneously during deconditioning (Burton, 1988; 
Greenleafet al., 1999; Shulzhenko et al., 1976; Vernikos, 1997; Vil-Vilyams and Shulzhenko, 1980). 
The efficacy of these two countermeasures, singly or in combination, has not been confiied on 
most physiological systems after prolonged BR-deconditioning. As a result, there are many questions 
to be addressed. For example: What is the most effective duration and intensity of exercise and 
acceleration? When performed simultaneously, do these two treatments interfere with each other? Will 
the muscle pumping action of exercising legs interfere with acceleration-induced caudal fluid shifts? 
Does daily exercise-acceleration training have salutary or adverse effects on the muscular, 
neurovestibular, or skeletal systems? 
The first studies utilizing the human-powered centrifuge (HPC) (Mulenburg and Vernikos, 1997) 
at Ames Research Center (ARC) began in 1995 (Chou, 1997; Chou et al., 1998; Greenleafet al., 1997, 
1999; Stad, 1998; Vener, 2000) and were designed to familiarize the investigators with its operating 
characteristics, procedures, and linearity of its loads as an exercise ergometer. Chou et al. (1997) have 
annotated most of the literature concerning the effects of exercise and acceleration training on 
deconditioning through 1996. 
The purpose of this study was to investigate exercise and acceleration training (singly and in 
combination) on metabolic, orthostatic, and blood and urine factors to provide background data in 
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preparation for a more extensive BR-deconditioning-training study. It was hypothesized that the three 
training protocols (Passive, Exercise, and Combined, all utilizing head-to-foot acceleration) would 
preserve normal orthostatic responses during tilt, and that the aerobic exercise conditioning stirnuli 
would not alter those +Gz training responses. 
METHODS 
Approval 
This experimental protocol entitled “Exercise Training on the Short-Arm Centrifuge” was 
approved by the San Francisco State University Committee for the Protection of Human Subjects on 
8 May 1998, and by the ARC Human Research Institutional Review Board on 4 January 1999 (H.R. 
No. 158 was replaced by No. 191). Approval of Dr. R. E. Grindeland’s addendum was granted on 
16 February 1999, and for a 1-month extension of H.R. No. 191 on 8 November 1999 (appendixes 
A1 - A4). Study data were collected from 14 June through 19 December 1999. 
Subjects 
The male test subjects were recruited from San Jose State University students and ARC employees 
and contractors. Seven men (table 1) were selected who were not currently involved in a regular 
physical training program, and who had no tobacco or nonprescriptive drug use. After extensive 
presentations of the experimental requirements and potential hazards by the investigators and medical 
monitor, the subjects signed informed consent forms and passed a comprehensive medical examination 
including history, electrocardiogram, blood and urine chemistry panels, and an exercise stress test prior 
to data collection. 
Human-Powered Centrifuge 
Desim. construction, operation, and instrumentation. The HPC, designed and constructed at Ames 
Research Center, is a short-arm (1.9 m ) dual-couch machine powered by a chain-linked cycle driven 
by the subject’s legs (fig. l)*. The revolving circular platform assembly consists of three lightweight 
aluminum honeycomb and bonded aluminum sections - a center section and two wings weighing a 
total of 295 kg. The center section, which rides on tapered roller bearings (Timken), supports the two 
couches and the chain-drive pedal mechanism. Bevel gears (Boston, 4: 1 gear ratio) transform pedaling 
power to platform rotation. The two wings, bolted to the center section, provide areas for walking and 
* Figures 1-1 1 are in the main text at the point of citation; figures 12-57 appear at the end of the report. In text, 
bracketed abbreviations designate concentrations; for example, plasma total protein [€“I. Simple initials are enclosed in 
the conventional parentheses following their definitions; for example, plasma renin activity (PRA). 
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Table 1. Test subject characteristics. 
5829 3.18 38 186 4.94 192 
I I 1 I I 
5510 3.31 40 188 5.47 1 79 
I I I I I 
7437 3.16 37 159 4.90 161 
4535 2.86 37 188 5.03 1 86 
5741 3.04 36 176 4.82 180 
900 0.32 4 12 0.38 10 
Phase I - Passive acceleration; Phase II - Exercise acceleration; Phase 111 - Combined acceleration. 
PV = plasma volume; TBV =total blood volume. 
infrared data tranwnmon, 
d laptop PC mounting area 
Subject vIdeo monilanng s s  
Center hub with 4.1 gear 
Standard bicyle chain 
Center section of platform 
............................ 
Bicycle for olf-plaiform operator 
Figure 1. The Human Powered Centrifuge 
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for mounting instrumentation. The three pedaling stations, two on-board at the end of the couches and 
the third located on the off-board operator's stationary cycle, are linked by standard bicycle chains and 
sprockets to the center hub. The top of the subject's head is located about 26 cm from the center of 
rotation, and the level of acceleration is calculated 1.9 m (6 ft) from the center of rotation. One 360" 
rotation of the platform requires 1.6 pedal sprocket rotations. Tables of acceleration as a function of 
angular velocity are given in appendixes B 1 and B2. 
The on-board subject and the off-board operator can actuate and control platform angular velocity 
(revolutions/min, rpm), but only the operator can stop the platform with a spring-set disc brake (Stearns 
series 87,300, model 1-087-352-00, Rexnord Corp., Milwaukee, Wis.) activated electronically by the 
operator or test subject. Centrifuge parameters, such as rpm (model H25D-SB encoder, BE1 Motions 
Systems, Co., Goleta, Calif., and model P6020 tachometer, Newport Electronics, Inc., Santa Ana, Calif.; 
total accuracy of 0.0002%) and G-level, are displayed on the control panel of the monitoring station. 
The center hub-drive differential has a slip-ring assembly (model 1067, Fabricast, South El Monte, 
Calif.) that transmits physiological data electrically from the on-board test subjects to instruments in the 
adjoining control room (fig. 1). 
In the current configuration, the second on-platform pedaling station is a standard independent 
cycle ergometer (model 845, Quinton Ergometer, Seattle, Wash.) that is not connected for platform 
rotation (fig. 2). For rotation while pedaling this ergometer, one of the other two pedaling stations must 
be engaged. There are three video cameras: one by each couch aimed at the subject's head, and the third 
covering the entire centrifuge. Subject energy output was measured with a metabolic (oxygen) analyzer 
(CPX Express, MedGraphics Corp., St. Paul, Minn.) with data downloaded and stored at the end of 
each run with a model H-1330 (Quantax Microsystems Corp., Somerset, N.J.) laptop computer, and 
then printed on the MedGraphics printer (model BJC, Canon Hi-Tech, Thailand). Heart-rate data were 
taken from the electrocardiogram (model 78202, Hewlett-Packard, Palo Alto, Calif.) and displayed in 
the control room. Information about all instruments and equipment is presented in appendix C. 
Protocol 
This study consisted of a 2-week pre-training period, three 3-week centrifuge training periods 
separated by two 4-week ambulatory recovery (deconditioning) periods, and a 4-week post-training 
ambulatory recovery (deconditioning) period (fig. 3). Daily protocols are presented in appendix D. 
The exercise and acceleration training regimens were conducted in three Phases: 
Phase I Passive acceleration) required the supine, resting subjects (no exercise) to ride the 
centrifuge at relative, intermittent loads that stepped between 25% and 50% of their maximal +Gz 
acceleration (+Gz,,J, provided by the off-platform cycle operator. Each subject underwent a 6-min 
warm-up at 25% followed by alternating 25% and 50% loads at 2-min intervals (0.008 Hz). for 30 min 
(fig. 4). The range of 50% +Gz- levels was 2.2 G to 2.5 G at the foot (table 2). 
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Figure 2. The Human Powered Centrifuge, top, bottom. 
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acceleration)* 
acceleration)’* 
111: Centrifuge 
Training Combined 
(HPC) 
Novl  3weeks Nov19 
(14 training sessions) 
(1 tilt test on day 15) 
t 
(BS) TILT (BS) 
t 
UA 
Groups A + B, N=6 
(combined acceleration)*** 
Recovery 
(deconditioning) 
Aug16 4weeks a p t 1 0  
t t 
t t 
maxV02 (BS) TILT (BS) 
MRI MRI 
t 
UA 
t 
maxV02 
t 
+GZV02 
Recovery 
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t t 
t t 
maxV02 (BS) TILT (BS) 
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t 
UA 
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maxV02 
t 
+GzVO2 
t 
.t 
(BS) TILT (BS) 
UA 
Group A; N=3 (passive 
acceleration)’* 
Group 8; N=3 (exercise + 
acceleration)* 
Tilt tests will be performed 1-2 days before pre-training and on the last day of the centrifuge training periods. 
MRI tests will be performed 2-3 days before pre-training and 1 day after the centrifuge training periods. 
Max V02 will be measured within a week before and 2 days after the centrifuge training periods. 
Max +Gz V02 will be measured within a week before the centrifuge training periods. 
UA: Urine analysis for markers of bone remodeling will be made from a 24-hr collection prior to tilt. 
BS: Blood samples will be drawn before and after each tilt test. 
* Exercise + acceleration = alternating ergometer exercise + constant off-platform acceleration. 
** Passive acceleration = alternating off-platform acceleration. 
*** Combined acceleration = human-powered centrifuge acceleration alternating exercise and accompanying acceleration. 
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LEGEND 
* Orientation = 
TiltB - 
Study - 
+OzmaxPt I = 
V02maxPt2 = 
MRI - 
HPCmaxPt 1 = 
HPCmaxPt2 = 
P 
E 
- 
- 
UrineCoII = 
No test subjects involved 
Test subjects involved. 
Subject familiarization with HPC, tilt, supine ergometer and VOzmax 
Tilt to +70" from horizontal for approximately 1 hr + blood samples. 
Measures to be used for study analysis. 
Maximal oxygen uptake preliminary assessment. 
Maximal oxygen uptake main assessment. 
Magnetic resonance imaging (noninvasive scan). 
Maximal oxygen uptake + centrifugation preliminary assessment . 
Maximal oxygen uptake + centrifugation main assessment. 
Subjects undertake passive centrifugation. 
Subjects undertake exercise during centrifugation. 
24-hr urine collection. 
Figure 3(b). 
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The Phase II (Exercise acceleration) protocol consisted of supine, oscillatory leg ergometer exercise 
varying from 40% of maximal oxygen uptake ( k12max) to 90% ?k02max in alternating 2-min intervals 
(fig. 5). The constant 50% +Gz- acceleration load was provided by the off-board operator. 
Phases I and II were conducted using a cross-over design with three subjects (Group A) 
undergoing exercise acceleration and three subjects (Group B) undergoing passive acceleration first; 
followed by the reverse in Phase II (fig. 1). The ranges of exercise loads (kg-mmin-') in Phase II were: 
(1,350-1,800) (table 2). 
40% (600-800), 50% (750- 1 ,000), 60% (900- 1,200), 70% ( 1,050- 1,400), 80% ( 1,200- 1,600), and 90% 
Phase ID (Combined acceleration) had the subjects exercising on the HPC arm of the centrifuge 
where their leg exercise drives the centrifuge; that is, the exercise and the acceleration were performed 
by the subjects. Here the 40% to 90% loads were determined previously from the +Gz- on the HPC 
arm expressed in revolutions per minute (fig. 6). The ranges of relative exercise acceleration (G-levels) 
were: 40% (1.8-2.2), 50 % (2.2-2.8), 60% (2.6-3.3), 70% (3.1-3.9), 80% (3.5-4.4), and 90% (4.0-5.0) 
(table 2 and appendix B). 
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The subjective intensity of perceived stress during the training sessions was noted by the subjects 
on the Borg (1982) scale (appendix D). 
FLE FRE HUN JAG RAY RUI SCH 
100% +Gr 4.40 4.51 4.50 4.94 5.47 4.90 5.03 G 
max . 
Passive - 13 13 26 26 26 13 
Sept Sept July July July Sept 
50% +Gz max - 2.2 2.2 2.4 2.5 2.5 2.5 G 
Tests and Measurements 
II 
Maximal oxygen uptake (@,max) protocol. Maximal working capacity was measured in the pre- 
training period with the subjects in the upright (sitting) and supine body positions (table 3) on 
calibrated electronically-braked ergometers (models 845 sitting and 846T supine, Quinton, Seattle, 
Wash.) where work output was independent of pedal rpm. Sitting and supine exercise were used prior 
to exercise-training data collection to familiarize the subjects with the protocol and to determine their 
maximal exertion data. The supine position was then used for all subsequent maximal exercise 
protocols at both positions on the centrifuge: the isolated Quinton (model 845) ergometer at one couch 
Exercise - 26 26 13 13 13 26 
(ergometer) July July Sept Sept Sept July 
Load in kg-m min-' 
50% +Gz max 2.4 1.8 2.5 2.8 2.4 2.2 G 
4oyo - 600 600 800 800 800 600 
50% - 800 750 1000 1000 1000 750 
60% - 1000 900 1200 1200 1100 900 
70% - 1100 1050 1400 1400 1300 1050 
80% - 1300 1200 1600 1600 1500 1200 
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60% 
70% 
80% 
90% 
2.6 2.8 2.6 2.9 3.3 3.1 - 
3.1 3.3 3.1 3.4 3.9 3.6 - 
3.5 3.8 3.5 3.8 4.4 4.2 - 
4.0 4.3 4.0 4.3 5.0 4.7 - 
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Table 3. Individual pre-training supine maximal ergometer exercise data on the seven men. 
RAY I 3.31 39.6 1.28 1 88 138 I 1700 10 
RUI 3.16 36.7 1.25 159 122 1900 9 
SCH 
I I I I I I I I 
e 
RER = respiratory exchange ratio; VE BTPS = ventilation; RPE = rated perceived exertion. 
2.86 37.2 1.26 1 88 99 1500 10 
and the combined HPC exercise + acceleration station at the other couch (fig. 7). The subjects were 
secured to the couches with shoulder braces and a four-point shoulder and lap harness; handgrips were 
used for body stabilization and leverage during the maximal tests. Thus arm, shoulder, and trunk 
muscular contractions were added to the lower leg exercise metabolism in determining V02max. A 
preliminary continuous HPC V02max test (Part 1) was performed 3 to 4 weeks before the main 
experiments in order to estimate the maximal workload (70 rpm with 300 kg-mmin-' increments until 
heart rate reached 180 bornin-' or volitional fatigue occurred); this was followed by a 5-min cooling- 
down period (fig. 8, left panel). After at least 3 days of recovery, the maximal exercise protocol (Part 2) 
was performed again (fig. 8, right panel) where the subjects warmed up at 70 rpm at about 40% of their 
maximal workload (0, uptake) determined in Part 1 above. They then exercised for 2-min intervals at 
progressively greater workloads starting at about 400 kg-mmin-' below the Part 1 estimated maximal 
load and continuing to 200 kg-m*min" below maximal; then the maximal load was undertaken. If the 
subjects completed 2 min at this "maximal" load, it was increased by 200 kg m*min-' each min until a 
heart rate of 180 b0min-l or volitional fatigue occurred. A 5-min cooling-down period followed. This 
abbreviated maximal testing protocol was used to minimize training effects. Heart rate, integrated from 
the EGG, and ratings of perceived exertion (WE) were recorded during all maximal tests. 
- 
X 
SD 
SE 
13 
I I 
3.04 36.4 1.26 176 113 1686 10 
0.32 3.9 0.05 12 14 157 0 
0.12 1.5 0.02 4 5 59 0 
Figure 7. 
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Time (min) Time (min) 
Figure 8 
Maximal human-powered centrifuge protocol. Re-training familiarization tests and tolerances were 
determined with the HPC (Greenleaf et al., 1999) 3 to 4 weeks before the experiments began (fig. 3). 
The subjects were secured in the couch with the 4-point restraint harness and to the pedals with toe- 
clips and Velcro@ straps; a blindfold was worn for all acceleration runs and radio headsets (model 
H3391, David Clark Co., Inc., Worchester, Mass.) were used to maintain communications among the 
subject, research team, and medical monitor (fig. 9). The preliminary test (Part 1) consisted of a 
9-min warm-up period at +0.5 Gz followed by 4 min at +1.0 Gz, 2-min rest, 4 min at +2.0 Gz, 2-min 
14 
Figure 9. 
rest, and then the maximal run (rpm) to volitional fatigue - followed by a cooling-down period (fig. 10, 
left panel). Then, after at least 3 days of recovery, the final maximal protocol (Part 2) was performed; it 
began with a 5-min warm-up period at about 40% of the maximal rpm (fig. 10, right panel). This was 
followed by 2 min at 60%, 2 min at 80%, and then increased by 20% of rpm-max*min-' until volitional 
fatigue - followed by a 5-min cooling-down period. Because of the physical constraints of the couch 
on the 1.9-m centrifuge radius, all of the taller subjects commented about being cramped during 
exercise, and felt that it attenuated their performance. 
Platform rpm (angular acceleration); that is, pedal cadence, was maintained with a digital tuner 
metronome (model DTM-12, Korg, Tokyo, Japan) through the subject's headset. Oxygen uptake, heart 
rate, ECG, WE (modified Borg scale), and Gz level and platform rpm were recorded during all 
maximal acceleration protocols. 
The CPX Express metabolic analyzer was calibrated by John Hoppe of Vacumetrics 
Inc.Nacu*Med Division. The difference between the CPX and Vacu*Med data are presented in 
appendix E. The mean respective 0, and CO, differences were -1.13 and 4.09% (medium range) and 
- 1.68 and +5.10% (high range). 
Tilt-table (orthostasis) protocol. After one practice tilting without blood sampling, the experimental 
tilt test was conducted before and after each phase (fig. 3) with the subjects initially in the horizontal, 
supine body position (fig. 11) on the tilt table (Physical Therapy Treatment Table, Laberne Mfg. Co., 
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Figure 1 1. 
Columbia, S.C.). After 35 min of supine rest (fig. 1 l), an 18-gauge Teflon catheter (Quick-Cath, Baxter 
Healthcare Corporation, Deerfield, Ill.) was inserted into the subject's right antecubital vein and 27 ml 
of blood collected for control measurements. Evans blue dye (T-1824 2.5 ml, 25 mg.5 ml-', New 
World Trading Corporation, DeBary, Ha.) was then injected through the catheter for determination of 
resting plasma volume (PV); the catheter was subsequently flushed with saline (0.9% NaC1, McGaw, 
Inc., Imine, Calif.). A venous blood sample (5 ml) was withdrawn at 10 min from the left arm and 
added carefully into a tube containing lithium-heparin. The table then was tilted to 70" head-up until 
the onset of pre-syncopal signs or symptoms such as a sudden decrease in systolic blood 
pressure > 25 mmHg.mid, decrease in diastolic blood pressure > 15 mmHgemin-', sudden drop 
in heart rate > 15 bomin-', accompanying nausea, clammy skin, perfuse sweating, or pallor. If none of 
these signs or symptoms was severe enough for termination, the test was stopped at 60 min. No subject 
reached unconsciousness. After only one +Gz- run subject RAY reported nausea, and subject SCH 
was dizzy, nauseated, and vomited after his run. Thus, both passive and active (exercise) acceleration 
resulted in far fewer adverse signs and symptoms than occurred after tilting (table 4). 
Blood (23 ml) was collected from the catheter (after waste withdrawal) following return of the 
subjects to the supine position (fig. 11). About 480 ml of blood were taken over the 20-week study 
period. A 24-hr urine sample was collected just prior to each tilt test (fig. 3). 
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Table 4. Individual baseline (BL) and pre- and post-training pre-syncopal signs-symptoms (PS-S) and tilt time for the 
Signs and symptoms 
17 
Table 4. Concluded. 
17 Dec OK 
RAY 29 Oct Sweating, nausea 
19 Nov Sweating, nausea 
17 Dec OK 
RUI 29 Oct OK 
19 Nov OK 
17 Dec OK 
SCH No Tilt 
28 No 
15 Yes 
41 Yes 
60 No 
60 No 
60 No 
60 No 
Physiological variables measured or calculated during the tilt test were heart rate from the ECG, 
thoracic impedance index, stroke volume (SV), and cardiac output (Q, Cardiodynamic monitor, BoMed 
Medical Mfg., Ltd., Irvine, Calif.). Additional measurements that were monitored continuously included 
noninvasive arterial pressure (model 2300, Finapres Ohmeda, Englewood, Colo.; calibrated with a W.A. 
Baum Co., Inc. Baumanometer sphygmomanometer, Copiague, N.Y.), radial arterial blood flow (model 
909, Parks Medical Electronic, Inc., Aloha, Oreg.), forearm skin perfusion (model PF4001, Perirned 
Periflux Smithtown, N.Y.), temple skin perfusion (model BPM 403A, LaserFlo Skin Perfusion 
Monitor, TSI, St. Paul, Minn.), and calf circumference with a sylastic strain gauge (model EC-4, 
D.E. Hokansen, Issaquah, Wash.); peripheral vascular resistance was calculated off-line from arterial 
pressure/cardiac output. All data were presented on a chart recorder (model MT 8800, Astro-Med, Inc., 
West Warwick, R.I.) and stored on an analog tape recorder (model MR-40, Teac, Japan) and in a 
computer (PC, Comteq Computer Co., Rockville, Md.; Windaq model DI-220, Dataq Instruments, Inc., 
Akron, Ohio) with a 250-Hz sampling rate. 
Blood samding; and analyses. After whole blood was allocated for hematocrit (Hct) and 
hemoglobin concentration [Hb] analyses, the remaining blood was placed into chilled and treated tubes 
and centrifuged for 15 min at 1,500 G at 4°C - except growth hormone samples which were 
centrifuged for 20 min at 1,OOO G (model RC2-B, Ivan Sorvall, Inc., Newton, Conn.). Hematocrit was 
measured immediately, while plasma for osmotic and Evans blue dye analyses was refrigerated at 4°C 
for analysis later that day. All other samples were stored at -70°C for analysis after the study. Tube 
treatment was potassium-EDTA plus 400 IU*mL' aprotinin for [Hb] and (PRA), [PVP], and [PA]; 
lithium-heparin for Hct, growth hormone (I-GH, B-GH, I-GF- l), and plasma osmotic, sodium, 
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potassium, albumin, and total protein concentrations; and EDTA plus reduced glutathione-saline-NaOH 
for [PE] and norepinephrine [PNE] concentrations. 
Plasma volume was measured in supine subjects with the Evans blue dye technique from one 10- 
min post-injection blood sample (Campbell et al., 1958; Greenleaf et al., 1979). Syringes (Beckton- 
Dickenson, Franklin Lakes, N.J.) used for dye injection were weighed pre- and post- injection (model 
B6 balance, Mettler Instrument Corp., Highstown, N.J.) to determine the amount of dye injected. Blood 
was centrifuged for 15 min at 1,500 G (4°C) and the plasma eluate was analyzed from Sephadex 
columns (No. PD-10, Pharmacia LKB Biotechnology, Uppsala, Sweden) and measured at an 
absorbency of 615 nm (model 35 spectrophotometer, Beckman Instruments Inc., Imine, Calif.). 
Percent change in post-tilt PV was calculated from the Hct and m] transformation equation 
(Greenleaf et al., 1979): 
100 [Hbs X (1- HCtA X lo-2)] 
[H bA X (I - HCtB X I O-*)] 
%APV = - 100 
where: B is before and A is after tilt. 
This equation has been validated for a period of only 2 hr, but F-cell ratio errors should have been 
minimized (more equal distribution of red blood cells) with the subjects in the supine position before 
tilt testing. The post-tilt PV data were back-calculated to milliliters from percent changes calculated 
from the Hb-Hct transformation equation. 
Hematocrit was measured in quadruplicate from microcapillary tubes, run for 10 min at 
1 1,500 rpm on an International Equipment Company Micro-MB centrifuge (Needham Heights, Mass.), 
and read on a modified microcapillary tube reader (model CR Micro-capillary reader, International 
Equipment Company, Needham Heights, Mass.) sensitive to k 0.1 Hct units. Raw Hct values were 
corrected for trapped plasma (0.96) and for whole body Hct (0.91). Blood m] was measured in 
duplicate with a cyanomethemoglobin method (Sigma Diagnostics@, St. Louis, Mo.). 
Plasma osmolality (+ 1 mosmol*kg&O-') was determined by freezing-point depression (model 3R 
osmometer, Advanced Instruments, Needham Heights, Mass.). Plasma total protein, albumin, sodium, 
and potassium analyses variability (k SD, cv) of 10 runs on one sample were determined with a 
Beckman Coulter Synchron analyzer (model LX20, Beckman Coulter, Inc., Brea, Calif.): total protein 
(k 0.05 g*dL-', 1.0) with the biuret reaction (Kingsley, 1942), albumin (k 0.05 go&-', 1.5) with 
Bromecresol purple binding (Pinnell and Northam, 1978), and indirect potentiomentry (electrodes) for 
both sodium (k 0.05 mmol*l", 0.4) and potassium (k 0.04 mmol.1-', 0.8) (Eisenman, 1967; Pioda et al., 
1969). 
Plasma hormone concentrations were analyzed by Helmut Hinghofer-Szalkay with 
radioimmunoassay, except the catacholamines which were analyzed by Michael Ziegler with the 
radioenzymatic method of Kennedy and Ziegler (1990). This modification of the catechol-o- 
methyltransferase (C0MT)-based radioenzymatic assay for [PNE] and [PE] improves sensitivity and 
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selectivity, and eliminates many inhibitors of COMT. prior to assay, the samples were extracted into 
heptane with diphenylborate and then put into dilute acetic acid. This extract 
efficiency of 78% for NE, but less than 2% for S-adenosylmethionine. The extraction procedure also 
excludes calcium and other COMT inhibitors present in urine, plasma, and every other tissue tested. 
This eliminated the requirement for individual standardization of tissue and urine samples. Sensitivity 
of the assay for PNE and PE in 1 ml of plasma was 10 and 6 pgml-', respectively. The respective intra- 
assay cv for PNE and PE were 4% and 13%, and the inter-assay cv for PNE and PE were 10% and 
16%, respectively, in human plasma containing low catecholamine levels. The assay permits 
quantitation of PE levels that were undetectable in prior assays. 
procedure has an 
Plasma aldosterone was measured with a modified radioimmunoassay (AldoCTK-2, Sorin 
Biomedica, Italy); its sensitivity, defined as the apparent concentration of analyte that can be 
distinguished from the zero standard, was below 20 pg0ml-l at the 95% confidence limit. The cv for the 
wihin- and between-assay variability was 9.7% and 11.5%, respectively. Plasma vasopressin was 
determined on ethanol-extracted plasma with a radioimmunoassay kit (Nichols Institue, Diagnostics 
BV, The Netherlands) with '251-AVP as the labeled compound. The anti-AVP antiserum did not cross- 
react with Lys8-vasopressin, oxytocin, or vasotocin. Sensitivity at the 99% confidence limit was 
1.3 pgoml-'. Plasma renin activity was determined by measurement of ANG-I (RENCTK, Sorin 
Biomedica, Italy) based on competition between labeled and native ANG-I to be assayed for a fixed 
number of antibody binding sites; PRA was expressed as nanograms of ANG-11 formed per milliliter 
of plasma after 1 hr of incubation. Sensitivity was c 0.20 ng0ml-I at the 95% confidence limit. 
Plasma growth hormone [PGH] was measured by radioimmunoassay (RIA) and bioassay by 
Richard Grindeland. Eight-milliliter aliquots of blood, obtained before and after each experimental 
treatment, were put into 15-ml plastic centrifuge tubes containing 100 ul(100 units) of heparin, mixed 
gently, and placed in an ice bath. These tubes were then centrifuged at 1,000 G for 20 min at 5°C and 
the plasma transferred to cryovials for storage at -70°C. The frozen samples were thawed in a 37°C 
water bath, care being taken to not unduly heat the plasma. An aliquot of 0.5 - 1.0 ml of plasma was 
left in each tube for the immunoassay; the balance was pooled by experimental treatment, the volume 
measured, and the pooled samples put into siliconized vials until injected into bioassay rats. The plasma 
was bioassayed according to the procedure of Greenspan et al., (1949) in 40-day-old female albino rats 
which had been hypophysectomized at 26 days of age by the vendor (Hilltop Laboratories, Scottsdale, 
Pa.). After surgery the rats were allowed to recover for 3 days and were then shipped to Ames Research 
Center where they were inspected and allowed to acclimate to the new environment and diet and to 
regain their body water balance. The assay rats were weighed 7 and 14 days after surgery; animals that 
gained more than 1 g of body weight per day over that interval were considered incompletely 
hypophysectomized and were not used in the assay. Rats that lost more than 2 g tdtal weight were also 
removed from the assay. 
Five rats were put into each treatment group or dose level of standard hormone. Three dose levels 
(1,5, and 15 pg to se) of standard bovine GH (1.5 IU*mg-') were employed. Pooled plasma, 
standard, or saline ected intraperitoneally (0.5 mloday-') for 4 days; on the fifth day the rats were 
euthanized with an overdose of CO, and a tibia dissected out, split longitudinally, and stained with 
silver nitrate. The stained tibias were put into individual vials containing 70% ethanol until the proximal 
growth plates were read microscopically (Carl Zeiss, Germany) to the nearest micrometer. Ten readings 
of the epiphyseal plate thickness were made, averaged for each rat, then averaged by group, and then 
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compared to a standard curve derived from bovine growth hormone standards. Because of the limited 
volume of plasma, only a single dose level of plasma was used. The mean EpGH] and 95% confidence 
limits were calculated using a "bracketed three point assay" (Bliss, 1952). The EpGm per milliliter of 
plasma was calculated as a function of the epiphyseal width. The bovine GH had a specific biological 
activity one half that of highly purified human GH, so values (ngml-') obtained from the standard 
curve were divided by 2 to yield human GH values. The commercial kits used for radioimmunoassays 
(Diagnostic Products, hc .  Los Angeles, Calif.) employed a double antibody system similar to the 
procedure of Utiger et al. (1962). Human growth hormone (hGH) standards (1-30 ngml-') or sample 
(100 pl) were pipetted into duplicate assay tubes. The standard hormone was NIH preparation 
NIAMDD hGH RP-1. Next, 100-pl aliquots of rabbit anti-human GH serum were added. The reagents 
were mixed on a vortex mixer and incubated for 1 hr at room temperature followed by addition of the 
radio-iodinated hGH, mixed again and incubated for another hour at room temperature. Then the cold 
second antibody (goat anti-rabbit gamma globulin) mixed with polyethylene glycol was added, the 
contents mixed, and the tubes centrifuged at 1,500 G for 30 min at 5°C. Except for one pair of tubes 
used to determine total counts, the supernatant was aspirated and the tubes were inverted to drain. The 
tubes were counted in a Packard Cobra model crystal scintillation counter for 1 min. After automatic 
subtraction of nonspecific binding, the results were plotted automatically as a log dose-logit curve and 
the results expressed as ng hGH*ml-'. The interassay coefficient of variation was 5% and the intraassay 
coefficient was 4%; outlier samples were reassayed. 
Urine collection and analyses. A 24-hr urine volume, collected just before each tilt test, was 
measured to 4 5 ml in a graduated cylinder and aliquots were frozen for subsequent analysis by Scott 
Smith. Urinary collagen cross-links (pyridinium, sensitivity 7.5 nmoles4-') and deoxypyrodinoline 
(sensitivity 1.1 nmoles4'') were determined with the PyrilinksTM and Pyri l inks-DTM kits, respectively 
(Metra Biosystems, Palo Alto, Calif.). Concentrations of n-telopeptide were measured with the 
Osteomark@ ELISA kit (Qstex International, Seattle, Wash.) which detects the n-telopeptide region of 
bone collagen specifically in human urine (Smith et al., 1998,1999) with a sensitivity of 20 nmoles4-'. 
Hydroxyproline analysis was performed on an amino acid analyzer (model L-8800, Hitachi Corp., San 
Jose, Calif.) using methods adapted from Paroni et al. (1992) and Slocum and Cummings (1990). 
Urine samples and internal standard (glucosaminic acid, TCI America, Portland, Oreg.) were 
hydrolyzed in 6N HC1 for 16 hr at 110°C. The hydrolysate was adjusted to a pH of 2.2 and 
concentrated using a Speedvac (Savant Corp., Holbrook, N.Y.). The solution was filtered through a 
0.2-pm filter and brought to volume with lithium buffer solution (pH 2.2). The protein-free filtrate was 
refrigerated until injected onto the analyzer. Post-column ninhydrin derivatization produces a 
chromagen detectable at 440 nm with a sensitivity of 0.021 pmolesml-'. Urinary calcium was 
determined using an atomic absorption spectrophotometer (model 4000, Perkin-Elmer, Norwalk, Mass., 
with a sensitivity of 5 mgodl-'). Creatinine was also determined spectrophotometrically (Owen et al., 
1954) with a sensitivity of 0.1 mgodl-'. 
Magnetic Resonance Imaging: MRI~. The lower body of each subject was imaged 2 days before 
and 1 day after completion of each of the 3-week training regimens on a 1.5 Tesla whole-body MR 
imager (Siemens Visionm, Iselin, N.J.) at Los Gatos MRI (Los Gatos, Calif.) by Peter Hardy. The 
subjects were supine with their feet at the center of the imaging magnet; their thighs were imaged by the 
body coil of the imager. Three types of images were obtained during each session: (1) 1-cm-thick T1- 
weighted images of the pelvis and thighs to estimate the volume of the rectus femoris, vastus lateralis, 
vastus intermedius, and vastus medialis; (2) a flow-alternating inversion recovery (FAIR) image 
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estimated perfusion of the quadriceps muscle; and (3) a multi-echo technique measured the spin-spin 
relaxation time (T2); that is, values proportional to the amount of work a muscle performs. The multi- 
echo spin images (T2) were calculated pixel-by-pixel for each of the five slices ac through the 
thighs. The IDL software allowed the user to select an arbitrarily defined region in the muscle from 
which to obtain basic statistics such as average and standard deviation over the region. The average T2 
in each head of the quadriceps muscle was extracted from the images taken before and after the 
subjects did a maximal number of deep knee bends. The change in T2 (T2,,, - T2P,) was calculated 
for a given muscle. 
Total imaging time was approximately 45 min. The M R  images were transferred onto magneto- 
optical disks for analysis at the University of Kentucky. The volumes of the four heads of the 
quadriceps muscle in each leg were determined by manually outlining the muscles using the 
commercially available image analysis software 3DVIEWNIX. Total muscle volume was the sum of the 
areas outlined on each image multiplied by the sliceto-slice separation. 
The T2 data were determined from the multi-echo images, using user-derived software, and 
perfusion data were derived from the FAIR images, using custom software written in IDL. 
DATA ANALYSIS 
Hemodynamic. A data analysis system devised by David Brown was developed for the Intel 
Windows platform using Microsoft Visual C. Analysis routines were designed to organize, group, 
scan, and average a large number of data sets to provide quick and easy access to signal processing, and 
to statistical and data base functions. A data collection system was developed using the Intel Windows 
platform and Microsoft Visual e++. Data acquisition used National Instruments E-series analog-to- 
digital converters and a full-screen high-performance mode to sample and display continuously up to 
16 channels of data at sample rates from 1 to 10,000 Hz (or higher depending on the AD board). 
All digitally sampled (250-Hz) wave forms (arterial pressure, peripheral flows, respiration, etc.) 
were analyzed to give both integrated mean values as well as spectral power results using the data 
analysis system described above. After R-wave detection, instantaneous R-R interval time series were 
constructed from the ECG. The resulting piecewise constant time series was low-pass filtered and 
sampled at 5 Hz. Auto- and cross-spectral estimates were computed using averaged periodograms. A 
Hanning window was used to reduce side-lobe error. Estimates of coherence were computed as a ratio 
of the squared magnitude of the cross spectrum divided by the product of the two autospectra. For each 
variable, the 10 min of resting control and 60 min of tilt data were divided into 200-sec segments for 
analysis. Mean values and spectral power from each rest and control period were averaged within 
subjects to enhance robustness. Results were then averaged across subjects for plotting and statistical 
analysis. 
Statistical. Means and standard deviations (+- SD) were calculated for subject characteristics, and 
means and standard errors (+ SE) were calculated for all other variables. The exercise, tilt, and blood 
variables were analyzed with a three-factor analysis of variance (SPSS 7.5 for Windows; SPSS, Inc., 
1996, Chicago, Ill.) with significant differences between the means determined with the Dunnett post- 
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hoc procedure. In addition, mean values and spectral power of the hemodynamic data were analyzed 
using a three-factor ANOVA (PC SAS version 6.12, SAS Institute, Inc., Cary, N.C.) to assess the 
significance of main effects: training protocols and tilting before and after training. When post-hoc 
testing was warranted (significant F-ratio for the effect of interest), t-statistics with degrees of freedom 
determined by Satherwaite’s approximation, were constructed to compare mean responses. In all cases 
statistical significance was determined at P < 0.05 and nonsignificant changes were NS. 
RESULTS 
Maximal Exercise (Passive, Exercise, Combined) Data 
Exercise load. The maximal exercise loads were increased (P < 0.05) for all three Phases after 
training (fig. 12a) in stepwise order from Passive (by 8.3 rt 4.3%), to Exercise (by 12.6 k 5.7%), to 
Combined (by 15.4 k 2.6%) (fig. 12b). 
Oxyen uptake. However, maximal oxygen uptake tended to decrease ( N S )  with Passive training 
and to increase (NS) with Exercise and Combined training (figs. 13a and 13b). 
Heart rate. Maximal exercise heart rates %) were decreased by 3 rt 2% ( N S )  with Passive, 
unchanged (0 k 2%) with Exercise, and tended to increase by 2 rt 2% ( N S )  with Combined training 
(figs. 14a and 14b). 
Exercise tolerance. Maximal exercise time to fatigue was unchanged (+2.6 rt 3.4%, NS) with 
Passive, but was increased by 6.0 f 4.9% (P < 0.05) with Exercise, and by 17.9 rt 3.2% (P c 0.05) with 
Combined training (figs. 15a and 15b). 
Orthostatic (Tilt-Table) Cardiovascular Data 
Resting pre-tilt heart rate. Resting HR (mean of 2 min before tilting) was unchanged with the three 
training Phases (fig. 16a), but was elevated by 12.9 f 5.2% (P c 0.05) after Passive training (fig. 16b). 
Resting pre-tilt systolic blood pressure. Mean resting SBP was unchanged after training in each of 
the respective Phases (fig. 17a). However, it tended to increase (NS) with Passive and decrease ( N S )  
with Exercise and Combined Phases (fig. 17b). 
Resting pre-tilt diastolic blood pressure. Mean resting DBP was also unchanged after training in 
each of the respective Phases (fig. 18a), and it also tended to be lower (NS) with Exercise and 
Combined Phases (fig. 18b). 
Resting pre-tilt mean arterial pressure. Average MAP followed the SBP and DBP with a tendency 
to increase ( N S )  with Exercise and Combined Phases (figs. 19a and 19b). 
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Tilt-tolerance time. Mean tilt-tolerance time pre- to post-training was increased only with Passive 
training from 43.5 f 7.2 to 54.7 1 5.3 min, respectively (fig. 20a); that is, by 37.8 f 19.6% 
(P < 0.05) (fig. 20b); tolerances were unchanged with the Exercise and Combined Phases. 
Heart rate at tolerance. Mean H R  at tolerance pre- to post-training was increased from 7 1 f 8 to 
89 f 7 bpm, respectively (fig. 21a); that is, by 29.1 f 7.7% (P < 0.05) with Passive training; H R  was 
unchanged with the Exercise and Combined Phases. 
Mean arterial pressure at tolerance. Average MAP at tolerance was increased from 88 f 13 to 
108 f 10 mmHg (by 33.4 f 18.896, P < 0.05) with Passive, and from 78 f 9 to 96 f 6 mmHg (by 28.8 
1 14.7%, P < 0.05) with Combined; Exercise MAP was unchanged (figs. 22a and 22b). 
Cardiac R-R interval with training. R-R intervals were not different at rest for the six treatments pre- 
and post-tilt for the three Phases (fig. 23). The greater the R-R interval, the slower the HR. But the 
intervals were uniformly lower (P < 0.05) for the six post-tilt treatments with no differences between or 
among Phases. 
Stroke volume with training. Stroke volume, similar to the R-R interval, was not different at rest for 
the six treatments for the three Phases (fig. 24), but it was uniformly lower (P < 0.05) at about 
60 mlobeat-' for the six post-tilt treatments with no differences between or among Phases. 
End-diastolic volume with training. E-D volume was not different at rest for the six treatments for 
the three Phases (fig. 25) but it was also uniformly decreased (P < 0.05) for the six post-tilt treatments 
with no differences between or among Phases. 
-. Cardiac ouput was not different at rest for the six treatments for the 
three Phases (fig. 26), and Q was uniformly decreased (P < 0.05) for the six post-tilt treatments with no 
differences between or among Phases. 
Cuff arterial pressure with training;. Arterial pressure was not different at rest or post-tilt for the six 
respective treatments for the three Phases (fig. 27). But all post-tilt values tended (NS) to be higher 
than their corresponding rest values. 
T k .  Total PR was not different at rest for the six treatments for 
the three Phases (fig. 28). But PR was uniformly increased (P < 0.05) for the six post-tilt treatments 
with no differences between or among Phases. 
Cardiovascular variables. (figs. 29a and 29b). 
Blood hemoglobin ml. Hemoglobin concentration was not different at rest for the six treatments 
or at post-tilt for the six treatments in the three Phases (fig. 30a). But Hb post-tilt was increased (P < 
0.05) for five treatments (except for post-Combined) reflecting decreases in plasma volume post-tilt. 
This is also indicated in the percent changes in €€b at rest and post-tilt (fig. 30b). Percent changes in 
Hb at tilt tolerance pre- and post-training (fig. 30c) indicate significant (P < 0.05) increases in five 
treatments-except for post-training in the Combined Phase. 
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Raw hematocrit (Hct). Hematocrit was not different at rest for the six treatments or at post-tilt for 
the six treatments in the three Phases (fig. 3 la). But Hct was uniformly increased (P < 0.05) for the six 
post-tilt treatments (reflecting decreases in plasma volume) with no differences between or among 
Phases. This also reflected decreases in plasma volume post-tilt that are reflected in the percent changes 
in Hct at rest and post-tilt (fig. 31b). Percent changes in Hct at tilt tolerance pre-and post-training 
indicated significant (P < 0.05) increases in all six treatments (fig. 31c). 
Plasma volume PV). Measured (T-1824) PV was not different at rest or post-tilt for the six 
treatments in the three Phases (fig. 32a). But PV was uniformly decreased (P < 0.05) for five 
treatments-except for post-training in the Combined Phase. These results are also indicated in the 
percent changes in Hct at rest and post-tilt (fig. 32b). Percent changes in PV at tilt-tolerance pre-and 
post-training (fig. 32c) indicate significant (P < 0.05) decreases for five treatments-except for post- 
training in the Combined Phase. 
Plasma sodium TpNal. Plasma sodium concentration varied between 136 and 138 mmolol-’ with 
post-tilt levels generally lower than comparable rest (pre-tilt) values, except for Exercise post-training 
(fig. 33a). Percent changes in [PNa] at rest and post-tilt (fig. 33b) were uniformly higher with Passive 
and Exercise Phases, when compared with essentially unchanged Combined data. Conversely, all 
percent changes in [PNa] at tolerance pre-and post-training were negative and varied form 0.4 to 0.8 
(all NS). Sodium accompanied the vascular-to-interstitial-fluid space shift of PV, so [PNa] remained 
unchanged. 
Plasma potassium TPK1. Plasma potassium concentration varied between 3.9 and 4.3 mmolol-’ at 
rest and post-tilt (fig. 34a), with reduced percent change at rest and post-tilt for the three Phases except 
for Exercise post-tilt (fig. 34b). Percent changes at tolerance with training were positive ( N S )  with 
Passive and Exercise and negative (NS) with Combined Phases; the greatest post-training increase in 
[PK] was with Exercise and the greatest decrease with Combine (fig. 34c). 
Plasma osmolality TpOsml. Plasma osmotic concentration varied between 286 and 289 mOsmokg-’ 
at rest and post-tilt with somewhat lower (NS) values post-tilt, except for Combined (fig. 35a). There 
were greater percent changes with training in Passive and Exercise, and the lower changes with 
Combined (fig. 35b) were qualitatively similar with comparable [PNa] responses. There was a minimal 
percent change in [POsm] with training at tilt-tolerance (fig. 35c) which was similar to comparable 
[PNa] changes in response to outward shifts of PV. Percent changes in [POsm] were in the same 
negative direction but were much smaller than comparable IpNa] shifts, and [PK] tended to increase. 
Plasma albumin rPAlb1. Plasma albumin concentration was increased (most P < 0.05) post-tilt pre- 
and post-training (fig. 36a). It tended to decrease (NS) at rest and post-tilt with training with Passive 
and Exercise, but to increase (NS) with Combined (fig. 36b). All percent changes at tolerance pre-and 
post-training were uniformly positive (range 5.1 % to 9.1 %), some sigruficantly increased from zero, 
with no difference among them (fig. 36c). These increases in IpAlb] reflect losses (shifts) in PV. 
Plasma total protein rpTpz . Plasma total protein concentration responses were qualitatively similar 
to those of [PAlb]: compare figures 36b and 37b, and 36c and 37c. 
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Plasma renin activity (PRA). Renin activity was not different at rest pre-and post-training and varied 
within the normal range; our data were 0.45 to 0.77 ngAngI*ml-'*hr-~ but all PFU were elevated 
(P c 0.05) post-tilt within the range of 1.51 to 2.47 ngAngI*ml-'* hr"! (fig. 38a). The percent change in 
both P W s  decreased (NS) with Passive, increased (NS) with Exercise, and were unchanged with 
Combined (fig. 38b). All percent changes in PRA at tolerance pre-and post-training were increased 
(P c 0.05) by 181% to 351% (fig. 38c). 
Plasma aldosterone PAI. In general, the [PA] responses were similar, as expected, to those of 
PRA. The rest [PA] were not different and were within the normal range; our data were 72 to 
115 pgeml""' (fig. 39a); but all [PA] values were elevated (P < 0.05) post-tilt within the range of 238 to 
276 pgeml-'. Percent changes in rest [PA] decreased by 29% (NS) with Passive but increased by 95% 
(NS) with Exercise; post-tilt [PA] were unremarkable (+0.7% and +20.5%, respectively) (fig. 39b). All 
percent changes in [PA] at tolerance pre-and post-training were increased by 67% to 45 1% in the 
Passive and Exercise Phases (fig. 39c) similar to comparable PRA data in fig. 38c. 
Plasma vasopressin TPVPI. Plasma vasopressin concentration at rest was at the high end of normal 
or higher with a range of 1.4 to 6.7 pgeml-' (fig. 40a). The resting Combined [PVP] were especially 
elevated at 6.7 and 4.0 pgeml-', respectively, post-tilt levels were greatly elevated with Passive (72.7 pre 
vs. 34.2 pgeml-' post) and Exercise (35.0 pre vs. 28.1 pg*ml-' post). Percent changes in [PVP] at rest 
and post-tilt with training varied considerably from -13.2% Combined post-tilt to 259.9% Exercise rest 
(fig. 40b). However, the percent changes in [PVP] at tilt-tolerance pre-and post-training were most 
diverse: the increases were about lO,OOO% with pre-and post-training Passive and pre-training Exercise; 
the other three varied form 83% to 957% (fig. 40c). 
Plasma epinephrine PEI. Plasma epinephrine concentration at rest was essentially unchanged 
among the six treatments; they varied from 25 to 31 pg*ml-' (fig. 41a). Post-tilt levels (except for 
Combined post-training) tended to be elevated (NS) from 47 to 106 pgoml-'. At rest the percent 
changes in [PE] pre- versus post-training were all positive for the three Phases, but all were negative 
post-tilt (fig. 41b). All percent changes in [PE] at tilt-tolerance pre-training and post-training (except 
Combined) were positive (range 80% to 268%) (fig. 41c). 
Plasma norepinephrine PNEI. Plasma norepinephrine concentration at rest was also essentially 
unchanged among those six treatments; they varied from 199 to 258 pg*ml-' (fig. 42a). All post-tilt 
levels were elevated (P c 0.05) from rest levels (range 381 to 581 pgeml-'). Percent changes pre- 
training versus post-training at rest and post-tilt varied within f 20% (fig. 42b). All percent changes in 
[PNE] at tilt-tolerance for the three Phases were increased (P < 0.05) by 90% to 132%; there were no 
differences among those six treatments (fig. 42c). 
Plasma dopamine PDI. Plasma dopamine concentrations at rest and post-tilt were variable but not 
significantly different among the six treatments (fig. 43a). Percent changes in [PD] post-tilt were 
attenuated compared to rest pre-training versus post-training for the three Phases (fig. 43b), and there 
were similar responses at tilt-tolerance pre- and post-training (fig. 43c). 
Plasma mowth hormone TPGHI. Plasma growth hormone concentration as measured by 
radioimmunoassay (RIA), with two exceptions, was essentially undetectable (value = 1) in the pre- 
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Phase resting periods (fig. 44a). At post-tilt it varied from 2.2 L- SE 1.1 ng*ml" (pre-Combined) to 
10.0 f 4.1 ng*ml-' with pre-Passive. Summed post-tilt levels were highest with Passive (10.0 + 4.5), 
somewhat lower with Exercise (3.7 + 5.4), and lowest with Combined (3.3 + 2.2) suggesting 
progressively less respective stress during tilting. Of the 16 cases (excluding baseline data) in Table 4 
who experienced post-training pre-syncopal signs and symptoms 0)s-S), 13 had increased (greater 
than 1) [PGH]; but there were 10 cases with increased [PGH] that did not have PS-S. Thus, onset of 
PS-S was minimally associated with increased [PGW. 
From bioassay data, the resting levels (with two exceptions of 1375 and 1205) ranged from 720 to 
775 ng HGHoml-' (fig. 44b). However, unlike the RIA findings, the summed post-tilt data were 
highest with Combined (2075 + 2000 = 4075), somewhat lower but similar with the Exercise 
(775 + 1850 = 2625) and Passive (2125 + 575 = 2700) Phases. Most individual Phase resting versus 
post-tilt values were significantly different except for post-Passive and pre-Exercise training. Clearly 
there are great individual differences in [PGH] after tilt that do not appear to be associated with pre- 
syncopal signs or symptoms. 
In like manner, about half of the post-exercise [PGH] were greater that 1 before and after 
Combined training (see PGH table in appendix F). 
Urine Data (24 hr) 
Urinarv volume and rate (24 hr). Urinary 24-hr volumes were not different between and among 
pre- and post-training samples for the three Phases (fig. 45). All urinary excretion rates (milliliters per 
minute) were within normal limits for uncontrolled food and fluid intakes. 
Urinarv variables: The urinary variables were creatinine (fig. 46), deoxypyridinoline (fig. 47), 
deoxypyridinoline / creatinine ratio (fig. 48), n-telopeptide (fig. 49), n-telopeptide / creatinine ratio 
(fig. 50), pyridinium cross-links (fig. 51), pyridinium cross-links / creatinine ratio (fig. 52), 
hydroxyproline (fig. 53), hydroxyproline / creatinine ratio (fig. 54), and calcium (fig. 55). There were 
no significant differences between or among these 24-hr urinary variables pre- or post-training for the 
three Phases; it is noted that the 24-hr sampling time may have been too short. 
Magnetic Resonance Imaging 
Volume. There was a significant (P c 0.05) increase of 4% to 6% in all four quadriceps muscle 
volumes (Tl), both right and left, post-Combined training (fig. 56). 
Excitation. Change in the multi-echo spin images (T2, excitation) of their muscles during pre- 
Combined training was correlated 0.79 (? = 0.62) with the number of knee bends, that is, the amount of 
muscular work (fig. 57). Each subject perfowed different numbers of knee bends according to his 
maximal ability. 
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SUMMARY OF RESULTS 
Maximal Exercise (Passive, Exercise, Combined) Data 
1. Maximal supine exercise loads increased significantly (P c 0.05) by 8.3% (Passive), by 12.6% 
(Exercise), and by 15.4% (Combined) after training, but their post-training maximal oxygen uptakes 
and maximal heart rates were unchanged. Maximal time to fatigue (endurance) was unchanged with 
Passive, but it too increased (P c 0.05) with Exercise and Combined training. Thus, the exercise in the 
Exercise and Combined training Phases resulted in greater maximal loads and endurance without effect 
on maximal oxygen uptake or heart rate. 
Orthostatic (Tilt-Table) Cardiovascular Data 
1. Resting pre-tilt heart rate was elevated by 12.9% (P c 0.05) only after Passive training, 
suggesting that the exercise training attenuated the H R  response. Resting pre-tilt blood pressures 
(SBR, DBP, MAP) were not different pre- or post-training in any Phase. Post-training tilt-tolerance 
time and heart rate were increased (P c 0.05) only with Passive training by 37.8% and by 29.1 %, 
respectively. Thus, addition of exercise training appeared to attenuate the increased Passive tolerance. 
2. Resting @re-tilt) and post-tilt cardiac R-R interval, stroke volume, end-diastolic volume, and 
cardiac output were all uniformly reduced (P e 0.05), and peripheral resistances were uniformly 
increased (P e 0.05) pre- and post-training for the three Phases, indicating there was no effect of the 
exercise training on these cardiovascular variables. 
Othostatic (Tilt-Table) Biochemical Data 
1. Plasma volume (percent change) was uniformly decreased by 8% to 14% (P e 0.05) at tilt- 
tolerance pre-training versus post-training, indicating essentially no effect of training on the level of 
hypovolemia. The latter was reflected in the 6% to 12% (P < 0.05) increase in [PAlb] and [PTP]. 
2. Percent changes in [PNa] pre-training versus post-training were minimal (less than -0.8%) as 
was [POsm] (less than -0.4%) indicating that plasma shifts during tilting were essentially isotonic. 
3. The percent changes in [PRA], [PA], [PE], and [PNa] exhibited similar characteristic increases at 
tolerance both pre- and post-training, whereas the usual increase in [PVP] was greatly attenuated post- 
training with Exercise, and pre- and post-training with Combined. The explanation for the latter is not 
obvious but is not likely a result of technical errors. 
Urine Data (24 hr) 
1. Urinary volumes were within normal limits (1.2 to 1.5 mlmin-') between and among pre- and 
post-training samples for the three Phases. 
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2. There were no significant differences between or among the 10 urinary variables pre- and post- 
training for the three Phases. 
Magnetic Resonance Imagining 
1. There was a 4% to 6% increase (P < 0.05) in all four quadriceps muscle volumes (right and left) 
after post-Combined training. 
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San Frmndseo State Unhrenlty 
1600 Holloway Avenue 
San Francisco. California 94132 
Ofke of Research and 
Sponsored Programs 
4 I5f338-223 I 
RATE 
MAY 08, 1998 
1 
JOHN E .  GREENLEAF, PR.D. 
NASA AMES RESEARCH CENTER 
MOFFETT FIELD, CA 94035-1000 
TO: r 
J~ L 
FROM: Associate Vice President fur Research and SponsoreU Programs 
SUBJECT: Protection of Human or Animal Subject Review of Research: 
EXERCISE TRAINING ON SHORT-ARM CENTRIFUGE, H.R.  NO. 158 
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APPENDIX A2 
National Aeronautlcs and 
Space Administration 
Ames Renearch Center 
Moffett Field, CA 94035-1OOO 
Reply 10 A1h o f  QR 243-2 January 4,1999 
TO John Greenleaf, Principal Investigator 
FROM: Chair, Human Research Institutional Review Board 
SUBJECT: Certification of Approval - HR I Protocol 
Your protocol, HR ## 191, “Exercise Training on the Shon-arm Centrifuge”, has 
been reviewed and approved by the Human Research Institutional Review Board. You are 
authorized to begin your research, subject to requirements as outlined in AMI 7170.1 
(Human Research Planning and Approval). Your approval date is December 7,1998. 
Approval expires on December 6,1999. 
The following conditions must be satisfied for your certification to remain in effect: 
1) Modificationdchanges in the project must be received and approved by the 
Human Research Institutional Review Board and/or by the Chairman, HRIRB 
before they are initiated, except when necessary, to eliminate immediate or 
apparent hazard to the subject. 
2) The office of the Chairman, HRIRB should be notified immediately of any 
injuries to human subjects andor any unanticipated problems that involve risks 
to human subjects or others. 
3) Copies of the approved consent form@) must be used for all investigational 
studies involving human subjects. In addition, all subjects must be given a 
copy of the consent form(s) to keep for their own records. 
4) The Depamnent of Health and Human Services and the FDA requires that the 
HRIRB conduct continuing review of ongoing research at intervals appropriate 
to the degree of risk, but not less than once per year. To meet this requirement, 
you must either submit a Protocol Status Report (Attachment A) by 
June 7,1999 or request to address the Board during the regulaily 
scheduled meeting preceeding this date . 
5) In addition, you are also required to complete a Protocol Renewal Request Form 
(see Attachment B) 6 weeks prior to your protocol expiration date if you wish to 
conduct research beyond the certification of approval expiration date. 
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National Aeronautics and 
Space Administration 
AIne8ReEeluchcenkrr 
Moffett Field, CA 94035-1oOO 
QH1243-2 February 16, 1999 Reply to Am of: 
TO: John Greenleaf, Principal Investigator 
FROM: Ralph Pelligra, Chair, Human Research Institutional 
Review Board (HRIRB) 
SUBJECT: Modification to HR I #191 entitled, “Human-Powered 
Centrifuge:Hormone Studies”, Co-Investigator, Richard E. 
Grindeland 
The proposed Subject modification was reviewed and approved by 
the HRIRB on Monday, February 8, 1999. 
Ralph Peiligra, M.D. 
cc: R. E. Grindeland 
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National Aeronautics and 
Space Administration 
Ames Research Center 
Moffett Field, CA 94035-1000 
Reply to Attn o f  
- 
QH: 243 -2 November 8, 1999 
To : Dr. John Greenleaf, Principal Investigator 
From: Ralph Pelligra, Chairman, Human Research Institutional 
Review Board (HRIRB) 
Subject: HRI-191, “Exercise Training on the Short-Arm 
C e n t r i f u g e” 
The HRIRB met on 11/1/99 and approved the following: 
1) A one-month extension of the Subject protocol 
2) The addition of two minutes of 1Gz passive warm-up; two 
minutes passive at 50% max; and two minutes of 1Gz passive 
exposure prior to HPC exercise and acceleration runs on Nov 2 
and Nov 17. 
1 0 / 4 / 9 9 .  
3) Your responses, dated 10/14/99, to the HRIRB requests of 
Please contact me if you have further questions. Thank you. 
Ralph Pelligra, M.D. 
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APPENDIX D 
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INTENSITY OF PERCEIVED EXERTION 
Supra-maximal 
Maximal 
Very, very strong 
Very strong 
Strong 
Somewhat strong 
Moderate 
Weak 
Very weak 
Very, very weak 
Nothing at all 
(almost max) 
(light) 
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APPENDIX E 
VacuMed 
Precision 0 2  Calibration 4% Metabolic Rate Calculation 
Line Data Description 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Enter Room Temperature (C): 
(10 - 39.2 Degree In 0.2 degree Intervals) 
Enter Bar0 Pressure (mmHg): 
LOW MEDIUM HIGH 
RANGE RANGE RANGE 
Enter Ambient Humidity (YO): 
Enter C02% of Metabolic CAL GA& 
Gas Flow Liters per Minute 
Metabolic Flow (ATPs3 in ml II.sjool~l j - 7 5 q  
IMetabolic Flow (STPD) in ml 1 1 4 6 4 )  1 1  
Correct CPX VOZ'(computed) to V02 (simulated) 
Enter system's exhaled Temp Assumption (C): 
(10 - 39.2 In 0.2 degree intervals) 
Vapor Pressure from Table': I I  * \  . ,_ "39.90 ,, ' ' - i- 
Enter system's V02 (computed stpd): 
Enter system's VC02 {computed stpd): 
ERROR VC02 
#ATPs = mixture of dry cal gas and room air is somewhat humid 
CPX Make & Model: 
Copyright 1998 Vacumetrics Inc 
W02CAL.4S 10 oct I990 
Comcted for Yo humidity 
John Hoppe 
President 
4483 McGrath St. # 102 Ventura CA 93003 
Fax (805) 6548759 mobile (8051 320-0654 
E-mail: info@vacumed.com 
Internet: w.vacumed.com 
Tel(805) 644-7461 * (800) 235-3333 
Serial No: Date: 
Sewing customen around the worM 
in me exercise ph- and cardiopulmonary 
sciences since 1968 
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~ ~ I passive I exercise I combined 
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RAY 
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Mean 
SD 
SE 
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297.2 146.9 68.3 99.7 48.6 137.2 127.2 
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APPENDIX G 
Fig. 12. Mean ( B E )  supine maximal exercise load for the three Phases. 
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Fig 13. Mean ( S E )  supine maximal oxygen uptake for the three Phases. 
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Fig. 14. Mean &SE) supine maximal heart rate for the three Phases. 
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Fig. 15. Mean (rtSE) supine maximal exercise tolerance for the three Phases. 
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Fig. 16. Mean (3zSE) resting pre-tilt heart rate for the three Phases. 
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Fig. 17. Mean &SE) resting pre-tilt systolic blood pressure for the three Phases. 
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Fig 18. Mean ( S E )  resting pre-tilt diastolic blood pressure for the three Phases. 
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Fig. 19. Mean (WE) resting pre-tilt mean arterial pressure for the three Phases. 
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Fig. 20. Mean ( S E )  tilt-tolerance time for the three Phases. 
6 0 .  
5 0 ,  
"1 60 T T T 
T 
50 
20 
10 
40 .  
30. 
2 0 ,  
10.  
0 -  
-10. 
-20. 
pre-training 
Q post-training 
- 
T 
Passive Exercise Combined 
a) Pre- versus post-training, min. 
-30 I 
Passive Exercise Combined 
b) After training, percent change. 
101 
Fig. 21. Mean (ME) heart rate at tilt-tolerance for the three Phases. 
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Fig. 22. Mean (+SE) arferial pressure at tilt-tolerance for the three Phases. 
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Fig 23. Mean (ME) cardiac R-R interval at rest and post-tilt, pre- and post-training for 
the three Phases. * P e 0.05 from corresponding rest value. 
140 
120 
A 100 
I, 
1 
.E 
B 
2 
(ij 
r 
80 
Y 
60 
(u - E,
3 40 
20 
0 
T T T T 
Pre Post Pie Post 
Exercise Passive 
Rest 
61 Post-tilt 
T 
Pre Post 
Combined 
Fig. 24. Mean (fSE) stroke volume at rest and post-tilt, pre- andpost-training for the 
three Phases. * P e 0.05 from corresponding rest value. 
1 04 
200 
T Y 150 
a - s
8 
Q 100 
8 
.- 
In m 
U 
U 
.- 
5 50 
0 
H Rest 
Post-tilt 
T T 
T T 
T 
Pre Post Pre Post Pre Post 
Exercise Passive Combined 
Fig. 25. Mean ( S E )  end-diastolic volume at rest and post-tilt, pre- and post-training 
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Fig 26. Mean ( S E )  cardiac output at rest and post-tilt, pre- and post-training for the 
three Phases. * P < 0.05 from corresponding rest value. 
105 
120 1 T 
100 
h 
Ol 
I 
E .  80 
E 
OY 60 
Y 
s 
E 
2 40 c a 
u) 
- 
20 
0 
Rest 
Q Post-tiit 
T 
T 
r 
T 
post-training for the three Phases. 
Rest 
Q Post-tilt 
*T 
* 
T * 
T 
* 
T 
* 
T 
- -I- -c -r 
Pre Post Pre Post Pie Post 
Exercise Passive Combined 
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post-training for the three Phases. * P c 0.05 from corresponding rest value. 
106 
Fig 29. Mean (WE) cardiovascular variables pre- and post-training for the three Phases. 
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Fig 30. Mean (ME)  blood hemoglobin at rest and post-tilt for the three Phases. 
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Fig. 31, Mean ( S E )  raw hematocrit at rest andpost-tilt for the three Phases. 
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Fig 32. Mean (&Sf) absolute plasma volume at rest and post-tilt for the three Phases. 
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Fig. 33. Mean (WE) plasma sodium concentration at rest and post-tilt for the three 
Phases. Normal range is 136 - 145 mmol L-l. 
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Fig. 38. Mean ( S E )  plasma renin ac& r2v at rest and ost-tilt for the three Phases. 
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Fig. 39. Mean @?E) plasma aldosterone concentration at rest and post-tilt for the 
Passive and Exercise Phases. Normal range (upright) is 50 - 200 pg m r ' .  
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Fig. 40. Mean ( H E )  plasma vasopressin concentration at rest and post-tilt for the 
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Fig 41. Mean ( S E )  plasma epinephrine concentration at rest and post-tilt for the 
three Phases. 
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Fig 42. Mean &SE) plasma norepinephrine concenm'on at rest and post-tilt for the three Phases. 
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Fig 43. Mean ( B E )  plasma dopamine concentration at rest and post-tilt for the three Phases. 
h 
a 700. 8 
600. T 
v) 
Op 500. 
Y 
c 
80 - 
70-  
n 7 60-  
z 
300. 
a 
8 250. 
n 
m 
E - E 200. 
c 
rn Rest 
h9 Past-tilt 
50 
Y 
@ E 
'E 40 
Q 
0 u 30 
20 
10 
0 
E 
Pre Post Pre Post Pre Post 
Passive Exercise Combined 
a. Pre- versus post-training, pg 0 m r l .  
Rest 
E3 Post-tilt 
U 5 400 - 
v) g 300 
i! 200 
*E 
g 100 
2 -100 
0 
W 
0 
h 
-200 1 
Passive Exercise Combined 
b) After training, percent change. * P < 0.05 from zero. 
350, rn pre-training 
69 post-training 
.c 3 150 
Q, 
S 
'E loo 
f o  m 
8 50 v 
m 
-50 
h 
-100 I 
Passive Exercise Combined 
c) Pre- versus post-training, percent change. 
121 
Fig. 44. Mean @E) plasma growth hormone concentration at rest and post-tilt for 
the three Phases. 
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Fig 46. Mean (&Sf) urinary creatinine excretion pre- and post-training for the three 
Phases, mg * 24 hr-l. 
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Fig 47. Mean (SE) urinary deoxypyridinoline excretion pre- and post-training for the 
three Phases, nmol 24 hr-l. 
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Fig 48. Mean (?SE) urinary deoxypyridinoline/creatinine ratio pre- and post-training 
for the three Phases nmoUnmol. 
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Fig 49. Mean ( S E )  urinary n-telopeptide pre- and post-training for the three Phases, 
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Fig 50. Mean (kSE) urinary n-telopeptiddcreatinine ratio pre- and post-training for the 
three Phases, nmol/nmol. 
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Fig 51. Mean 4SE) urinary pyridinium crosslinks pre- and post-training for the three 
Phases, nmol 24 hr-'. 
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Fig 52. Mean (WE) urinary pyridinium crosslinks/creatinine ratio pre- and 
post-training for the three Phases, nmol/nmol. 
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Fig. 54. Mean (kSE) urinary hydroxyprolindcreatinine ratio pre- and post-training for 
the three Phases, gmol&mol. 
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Fig 55. Mean &SE) urinary calcium excretion pre- and post-training for the three 
Phases, mg * 24 hr-l. 
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